These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37655946)

  • 1. [A multi-resistant bacterium before the era of antibiotics: the agent of melioidosis].
    Buisson Y
    C R Biol; 2024 Mar; 346(S1):17-21. PubMed ID: 37655946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions.
    Currie BJ
    Eur Respir J; 2003 Sep; 22(3):542-50. PubMed ID: 14516149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melioidosis.
    Wiersinga WJ; Virk HS; Torres AG; Currie BJ; Peacock SJ; Dance DAB; Limmathurotsakul D
    Nat Rev Dis Primers; 2018 Feb; 4():17107. PubMed ID: 29388572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment.
    Currie BJ
    Semin Respir Crit Care Med; 2015 Feb; 36(1):111-25. PubMed ID: 25643275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fatal Case Of Persistent Burkholderia Pseudomallei Bacteraemia With Severe Pneumonia And Splenic Abscess.
    Chang CY; Lee HL
    J Ayub Med Coll Abbottabad; 2023; 35(2):331-333. PubMed ID: 37422833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of Tubo-ovarian abscess caused by Burkholderia pseudomallei.
    Nernsai P; Sophonsritsuk A; Lertvikool S; Jinawath A; Chitasombat MN
    BMC Infect Dis; 2018 Feb; 18(1):73. PubMed ID: 29422033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.
    Trevino SR; Dankmeyer JL; Fetterer DP; Klimko CP; Raymond JLW; Moreau AM; Soffler C; Waag DM; Worsham PL; Amemiya K; Ruiz SI; Cote CK; Krakauer T
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009125. PubMed ID: 33571211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
    Schweizer HP
    Future Microbiol; 2012 Dec; 7(12):1389-99. PubMed ID: 23231488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less is more: Burkholderia pseudomallei and chronic melioidosis.
    Nandi T; Tan P
    mBio; 2013 Sep; 4(5):e00709-13. PubMed ID: 24065633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Melioidosis.
    Gassiep I; Armstrong M; Norton R
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32161067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within-Host Evolution of
    Viberg LT; Sarovich DS; Kidd TJ; Geake JB; Bell SC; Currie BJ; Price EP
    mBio; 2017 Apr; 8(2):. PubMed ID: 28400528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melioidosis: Case reports of confirmed Burkholderia pseudomallei in Saudi Arabia.
    Alhatmi H; Alharbi A; Bosaeed M; Aldosary O; Aljohani S; Alalwan B; Alsaeedi A; Almahmoud S; Alothman A
    J Infect Public Health; 2020 May; 13(5):824-826. PubMed ID: 32156532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
    Sarovich DS; Price EP; Von Schulze AT; Cook JM; Mayo M; Watson LM; Richardson L; Seymour ML; Tuanyok A; Engelthaler DM; Pearson T; Peacock SJ; Currie BJ; Keim P; Wagner DM
    PLoS One; 2012; 7(2):e30789. PubMed ID: 22363490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection.
    Propst KL; Troyer RM; Kellihan LM; Schweizer HP; Dow SW
    Antimicrob Agents Chemother; 2010 May; 54(5):1785-92. PubMed ID: 20176901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of ceftazidime against Burkholderia pseudomallei, the causative agent of melioidosis.
    Cummings JE; Lunde CS; Alley MRK; Slayden RA
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011795. PubMed ID: 38011278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
    Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
    Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated liver abscesses in melioidosis.
    Mukhopadhya A; Balaji V; Jesudason MV; Amte A; Jeyamani R; Kurian G
    Indian J Med Microbiol; 2007 Apr; 25(2):150-1. PubMed ID: 17582188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis.
    Currie BJ
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):225-7. PubMed ID: 18166205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.